17-14069166-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The ENST00000449363.2(COX10-DT):n.207+106G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0516 in 191,130 control chromosomes in the GnomAD database, including 322 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.054 ( 288 hom., cov: 32)
Exomes 𝑓: 0.042 ( 34 hom. )
Consequence
COX10-DT
ENST00000449363.2 intron
ENST00000449363.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.439
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 17-14069166-C-T is Benign according to our data. Variant chr17-14069166-C-T is described in ClinVar as [Benign]. Clinvar id is 1273311.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.073 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COX10-DT | NR_049718.1 | n.187+106G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COX10-DT | ENST00000449363.2 | n.207+106G>A | intron_variant | 2 | ||||||
COX10-DT | ENST00000582752.7 | n.212+106G>A | intron_variant | 3 | ||||||
COX10-DT | ENST00000602539.3 | n.207+106G>A | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0541 AC: 8231AN: 152150Hom.: 288 Cov.: 32
GnomAD3 genomes
AF:
AC:
8231
AN:
152150
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0420 AC: 1633AN: 38862Hom.: 34 AF XY: 0.0391 AC XY: 793AN XY: 20298
GnomAD4 exome
AF:
AC:
1633
AN:
38862
Hom.:
AF XY:
AC XY:
793
AN XY:
20298
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0540 AC: 8229AN: 152268Hom.: 288 Cov.: 32 AF XY: 0.0556 AC XY: 4142AN XY: 74436
GnomAD4 genome
AF:
AC:
8229
AN:
152268
Hom.:
Cov.:
32
AF XY:
AC XY:
4142
AN XY:
74436
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
106
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 28, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at